Skip to content
Subscriber Only

Pfizer, BioNTech Covid Vaccine Cleared for Human Tests

  • BioNTech’s shares soar after regulator gives go-ahead
  • Testing on 200 healthy people in Germany to start shortly
Covid-19 Swab Testing at France's LBM LxBio Laboratory
Photographer: Balint Porneczi/Bloomberg
Updated on

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Pfizer Inc. and BioNTech SE secured approval for Germany’s first human clinical trials of a possible coronavirus vaccine, entering a global race to develop a defense against the pandemic.